Abstract
Prevalence of High-Risk Human Papillomavirus Serotypes and Confrontation with Available Vaccine Antigens: The Case of Cameroon
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have